- Home
- ALXO vs LBGJ Comparison
ALXO vs LBGJ Comparison
Compare ALXO & LBGJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALXO
- LBGJ
- Stock Information
- Founded
- ALXO 2015
- LBGJ 2007
- Country
- ALXO United States
- LBGJ China
- Employees
- ALXO N/A
- LBGJ N/A
- Industry
- ALXO Biotechnology: Pharmaceutical Preparations
- LBGJ
- Sector
- ALXO Health Care
- LBGJ
- Exchange
- ALXO Nasdaq
- LBGJ NYSE
- Market Cap
- ALXO 24.0M
- LBGJ 24.7M
- IPO Year
- ALXO 2020
- LBGJ 2024
- Fundamental
- Price
- ALXO $0.41
- LBGJ $1.47
- Analyst Decision
- ALXO Strong Buy
- LBGJ
- Analyst Count
- ALXO 6
- LBGJ 0
- Target Price
- ALXO $3.30
- LBGJ N/A
- AVG Volume (30 Days)
- ALXO 613.7K
- LBGJ 72.1K
- Earning Date
- ALXO 08-07-2025
- LBGJ 06-17-2025
- Dividend Yield
- ALXO N/A
- LBGJ N/A
- EPS Growth
- ALXO N/A
- LBGJ N/A
- EPS
- ALXO N/A
- LBGJ N/A
- Revenue
- ALXO N/A
- LBGJ $11,781,015.00
- Revenue This Year
- ALXO N/A
- LBGJ N/A
- Revenue Next Year
- ALXO N/A
- LBGJ N/A
- P/E Ratio
- ALXO N/A
- LBGJ N/A
- Revenue Growth
- ALXO N/A
- LBGJ 21.82
- 52 Week Low
- ALXO $0.40
- LBGJ $1.02
- 52 Week High
- ALXO $8.78
- LBGJ $5.50
- Technical
- Relative Strength Index (RSI)
- ALXO 40.22
- LBGJ N/A
- Support Level
- ALXO $0.45
- LBGJ N/A
- Resistance Level
- ALXO $0.53
- LBGJ N/A
- Average True Range (ATR)
- ALXO 0.05
- LBGJ 0.00
- MACD
- ALXO -0.01
- LBGJ 0.00
- Stochastic Oscillator
- ALXO 4.98
- LBGJ 0.00
About ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
About LBGJ LI BANG INTERNATIONAL CORPORATION I
Li Bang International Corp Inc is a holding company. The firm through its subsidiaries engages in designing, developing, producing, and selling stainless steel commercial kitchen equipment in China under its own Libang brand. In addition, its subsidiaries provide customers with comprehensive services, from commercial kitchen design in the early stage to equipment installation and after-sales maintenance.